Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 34M P/E - EPS this Y 82.80% Ern Qtrly Grth -
Income -15.21M Forward P/E -0.63 EPS next Y 1.40% 50D Avg Chg -8.00%
Sales 278k PEG - EPS past 5Y - 200D Avg Chg -25.00%
Dividend N/A Price/Book 3.58 EPS next 5Y - 52W High Chg -65.00%
Recommedations 1.70 Quick Ratio 2.30 Shares Outstanding 5.58M 52W Low Chg 34.00%
Insider Own 15.53% ROA -74.66% Shares Float 35.14M Beta -0.26
Inst Own 8.19% ROE -802.80% Shares Shorted/Prior 22.05K/45.42K Price 1.23
Gross Margin 100.00% Profit Margin - Avg. Volume 214,493 Target Price 10.85
Oper. Margin -2,974.68% Earnings Date Dec 17 Volume 18,325 Change -2.38%
About Evaxion Biotech A/S

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based vaccine that is in Phase 1/2a trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers. Its programs also include some vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, viral vaccine product candidate for targeting Cytomegalovirus. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.

Evaxion Biotech A/S News
11/13/24 Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing
11/12/24 EVAX Racks up Positive Test Results
11/12/24 Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
10/31/24 Evaxion announces business update and third quarter 2024 financial results
10/31/24 EVAX Exceeds Estimates and Confirms Partnership
10/28/24 Evaxion to announce business update and third quarter 2024 financial results on October 31
10/11/24 OTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCR
10/09/24 Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
10/04/24 Evaxion Biotech Charts Future with Innovative Immune Therapies
10/03/24 AI from EVAX Improves Trial Results
10/03/24 Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform
09/26/24 Evaxion significantly expands vaccine development collaboration with MSD
09/26/24 EVAX Process Continues to Garner Interest and Investment
09/20/24 Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
09/19/24 Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction
09/16/24 Life Sciences Virtual Investor Forum Agenda Announced for September 19th
09/16/24 Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01
09/09/24 Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01
09/09/24 Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2
09/09/24 EVAX Uses AI Platform to Generate Positive Treatment Data
EVAX Chatroom

User Image Manwiththeplan Posted - 2 hours ago

$EVAX https://www.euractiv.com/section/health-consumers/news/denmark-and-sweden-launch-ambitious-new-life-science-strategies/

User Image Manwiththeplan Posted - 1 day ago

$EVAX i have to say that i dont understand why they didnt do the offering 2 months earlier. It could have prevented the delisting notification and share price was much higher

User Image beautinvest Posted - 1 day ago

$EVAX what the fucks up its gucciman the G

User Image Gu4 Posted - 2 days ago

$EVAX delisted

User Image Manwiththeplan Posted - 2 days ago

$EVAX

User Image Lenni_D Posted - 2 days ago

$EVAX Basis for compliance should be done here EOD with an offering without warrants (except for prefunded warrants). That’s good and should give the SP room to move up - if not straight away then at least when the next deal is announced just before or after Jan 1 and further when MSD exercises the options in 2025 (early 2025 imo).

User Image Manwiththeplan Posted - 2 days ago

$EVAX https://investors.evaxion-biotech.com/node/9541/html

User Image Manwiththeplan Posted - 2 days ago

$EVAX my price target 14 next year

User Image Manwiththeplan Posted - 2 days ago

$EVAX i think run will start in januari, but it could start earlier

User Image Manwiththeplan Posted - 6 days ago

$EVAX buy low sell high. 2025: - 10 million from merck - equity problem solved - nasdaq compliance - deal or multiple deals

User Image Tradezeez Posted - 6 days ago

$EVAX

User Image Manwiththeplan Posted - 6 days ago

$EVAX i understand the delisting risk, but this pipeline is worth more then 8 million.

User Image Manwiththeplan Posted - 6 days ago

$EVAX i think ppl have 2 to 3 month before explosion

User Image PenkeTrading Posted - 1 week ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Evaxion Biotech AS. Is that bullish or bearish? $EVAX #Evaxion #RsiOversold #NASDAQ

User Image Manwiththeplan Posted - 1 week ago

$EVAX wasnt expecting this drop today. People that sold today didnt follow the news

User Image Line_Line Posted - 1 week ago

$EVAX opportunity here

User Image Gu4 Posted - 1 week ago

$EVAX 💔

User Image Stmkr Posted - 1 week ago

$EVAX Although not surprising (I am used to these dips) NASDAQ delisting notice was expected. So fundamentaly the timing of the dip today does not make sense. Unless I am missing some other news?

User Image Catracho5 Posted - 1 week ago

$EVAX Under $1 soon?🤔

User Image Lenni_D Posted - 1 week ago

@Manwiththeplan $EVAX CEO is teasing for a deal around jan 1st and they will receive 10m $ from MSD 1H 2025 imo (basically only pending some paper work) which will solve the equity compliance problem. I just picked up 3k+ shares at this crazy level. I'm fully loaded and am ready to for a 2025 partnership bonanza.

User Image Manwiththeplan Posted - 1 week ago

$EVAX they have +- till may 2025 to come up with big news

User Image Manwiththeplan Posted - 1 week ago

$EVAX https://finance.yahoo.com/news/evax-racks-positive-test-results-140000566.html By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current ...

User Image Manwiththeplan Posted - 1 week ago

$EVAX every vaccin/antigene this company makes is working. And I seem to be the only one who thinks this could be a winner. Well i dont care nobody is watching this

User Image Manwiththeplan Posted - 1 week ago

$EVAX https://www.globenewswire.com/news-release/2024/11/12/2979034/0/en/Evaxion-announces-positive-preclinical-data-for-cytomegalovirus-CMV-vaccine-program-EVX-V1.html

User Image Lenni_D Posted - 2 weeks ago

$EVAX From X: We are pleased to announce our participation in this year’s International Conference on Vaccines Research & Development in Boston. Don’t miss our Senior Project Manager, Gry Persson, presenting on Nov 12 at 9:40 AM EST on how our AI-Immunology™ platform is advancing cytomegalovirus vaccine development.

User Image Manwiththeplan Posted - 2 weeks ago

$EVAX this looks like the bottom for now after the possible delisting news. Partnership news can be expected in q1 2025. I think share will start going up end of 2024. Happy holding for now. Next year we will have partnerships, money coming in and nasdaq compliance news. End 2025 we have been bought or share price is 10 dollar. Years after that will be better

User Image Manwiththeplan Posted - 2 weeks ago

$EVAX i am thinking about this situation. The fact there is no dilution to raise equity is a bit strange but for me also a sign a very significant partnership or buyout is coming. I listened to the CC and they sound very confident about a coming partership in the next months. (Probably Q1 2025) I am holding.

User Image Manwiththeplan Posted - 10/31/24

$EVAX shame they could not solve the delisting risk. Strange they are not trying harder. They have solid results. They are clear about partnerships. I think there is a buyout coming

User Image Marlin308 Posted - 10/31/24

$EVAX https://finance.yahoo.com/news/evaxion-announces-business-third-quarter-120000102.html

User Image Manwiththeplan Posted - 10/29/24

$EVAX buy now. Thank me later

Analyst Ratings
HC Wainwright & Co. Buy Sep 26, 24
HC Wainwright & Co. Buy Sep 20, 24
HC Wainwright & Co. Buy Aug 16, 24
HC Wainwright & Co. Buy Aug 1, 24
HC Wainwright & Co. Buy Jun 4, 24
HC Wainwright & Co. Buy Apr 3, 24
Ladenburg Thalmann Buy Apr 2, 24
HC Wainwright & Co. Buy Mar 20, 24
HC Wainwright & Co. Buy Feb 12, 24